by Richard Daverman, PhD
March 7, 2014 -- Biostar Pharma, a China maker of pharmaceuticals and health supplements, signed a letter of intent to develop Oleanolic acid injection as a treatment for liver cancer with Shaanxi University of Chinese Medicine. Biostar’s best-selling product is its Xin Aoxing Oleanolic Acid Capsule, an OTC medicine for chronic hepatitis B. Terms of the proposed deal were not disclosed, but Biostar did say it was prepared to invest a large amount of capital and resources into the project, More details....
Stock Symbol: (NSDQ: BSPM)
Help employers find you! Check out all the jobs and post your resume.
